dipyridamole

(redirected from Aggrenox)
Also found in: Medical.
Related to Aggrenox: dipyridamole

di·pyr·id·a·mole

 (dī-pĭr′ĭ-də-mōl′, dī′pə-rĭd′ə-mōl′)
n.
A drug, C24H40N8O4, that acts as a coronary vasodilator and is used in the long-term treatment of angina pectoris and as an antiplatelet agent.

Translations

dipyridamole

n dipiridamol m
References in periodicals archive ?
Important Safety Information About Aggrenox [R] (aspirin/extended-release dipryidamole) AGGRENOX is a prescription medication used to lower the risk of stroke in people who have had a "mini-stroke" (transient ischemia attack or TIA) or stroke due to a blood clot.
Under this agreement, Duramed Pharmaceuticals is required to co-promote Aggrenox to obstetricians, gynecologists and other practitioners with a focus on women's healthcare in the United States using its Specialty Sales Force.
The study did not meet its primary endpoint of non-inferiority for AGGRENOX versus clopidogrel.
The Company believes that it is the first to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for Aggrenox.
Health Economic Model Assesses Cost-Effectiveness of Aggrenox vs.
The committee's recommendation, while not binding, will be considered by the FDA in its review of the New Drug Application (NDA) for AGGRENOX.
The proposed indication for AGGRENOX is to reduce the combined risk of death and non-fatal stroke in patients who have experienced a transient ischemic attack (TIA) or completed ischemic stroke.
These three drugs have never been directly compared, but data from separate studies that have compared them with aspirin suggest that Aggrenox may be more effective than clopidogrel, shown to reduce the risk of stroke 8% over aspirin alone, said Dr.
Oral antiplatelets currently approved for sale in the United States include aspirin, Ticlid (ticlopidine-Roche), Aggrenox (dipyridamole and aspirin-Boehringer Ingelheim) and Plavix (clopidogrel-Bristol-Myers Squibb and Sanofi Aventis).
The allegations involved the off-label marketing of four drugs: Aggrenox, Atrovent, Combivent and Micardis.